NAMS Menopause Certification Exam
2026/2027
Complete Questions and Solutions
Aligned with 2026-2027 The Menopause Society (formerly NAMS)
Certified Menopause Practitioner (NCMP) Examination Blueprint
Total Questions Question Format Cognitive Levels
25% Recall, 55% Application, 20%
100 MCQ (A-D), Single Best Answer
Analysis
Section 1: Menopause Physiology - Normal and Abnormal (Q1-Q20)
Section 2: Health Disorders of Peri- and Postmenopausal Women (Q21-Q35)
Section 3: Clinical Evaluation and Diagnostic Approach (Q36-Q50)
Section 4: Therapeutic Options - Hormone Therapy (Q51-Q65)
Section 5: Therapeutic Options - Non-Hormonal and Integrative Therapies (Q66-Q75)
Section 6: Bone Health and Osteoporosis Management (Q76-Q85)
Section 7: GSM and Sexual Health (Q86-Q92)
Section 8: Cardiovascular Health, Cancer Screening, and Long-Term Preventive Care (Q93-Q100)
1
,Section 1: Menopause Physiology - Normal and Abnormal
Q1: A 52-year-old woman presents to the clinic reporting irregular menstrual cycles over the past 8
months. Her cycles previously occurred every 28 days but now vary from 21 to 45 days. According to the
STRAW+10 staging system, which stage of reproductive aging best describes this patient?
A. Stage -2 (Early Transition) **[CORRECT]**
B. Stage -1 (Late Transition)
C. Stage +1a (Early Postmenopause)
D. Stage -3 (Late Reproductive)
Correct Answer: A
Rationale: The STRAW+10 staging system defines Stage -2 (Early Transition) by a persistent difference of 7 or more days in
the length of consecutive cycles. This patient's cycle variability (21-45 days, a difference exceeding 24 days) meets this
criterion. Stage -1 requires 60 or more consecutive days of amenorrhea, which is not reported here. Stages +1a and -3 do not
match the clinical presentation of cycle irregularity.
Q2: A 47-year-old woman reports that she has not had a menstrual period for the past 10 weeks. Prior to
this, her cycles had become increasingly irregular over the preceding year. Based on STRAW+10 criteria,
what is the minimum duration of amenorrhea required to classify her as being in the Late Menopausal
Transition (Stage -1)?
A. 30 consecutive days
B. 45 consecutive days
C. 60 consecutive days **[CORRECT]**
D. 90 consecutive days
Correct Answer: C
Rationale: The STRAW+10 staging system defines Stage -1 (Late Menopausal Transition) by the occurrence of 60 or more
consecutive days of amenorrhea. This patient meets the criterion with 70 days (10 weeks) of amenorrhea. Thirty days
represents a single missed cycle insufficient for staging. Forty-five days does not meet the STRAW+10 threshold. Ninety days
is excessive and not the defined criterion.
Q3: A clinician is educating a 38-year-old woman who was recently diagnosed with Primary Ovarian
Insufficiency (POI). Which of the following laboratory findings is most consistent with this diagnosis?
A. FSH level of 15 IU/L on a single measurement
B. FSH level of 30 IU/L on two measurements 4 weeks apart **[CORRECT]**
C. Elevated prolactin with normal FSH
D. Low estradiol with normal FSH and LH
Correct Answer: B
Rationale: POI is diagnosed in women under age 40 with amenorrhea for 3-4 months and elevated FSH of 25 IU/L or greater
on two checks performed 4-6 weeks apart. An FSH of 30 IU/L confirmed on two separate measurements meets this diagnostic
criterion. A single FSH measurement of 15 IU/L is insufficient and below the threshold. Elevated prolactin suggests a
different etiology. Low estradiol with normal gonadotropins points toward hypothalamic amenorrhea rather than POI.
Q4: A 55-year-old woman asks her healthcare provider when she can be formally diagnosed as
postmenopausal. According to NAMS guidelines, which of the following is the correct diagnostic criterion
2
,for natural menopause?
A. FSH level greater than 40 IU/L on two occasions
B. Twelve consecutive months of amenorrhea without other pathological or physiological cause
**[CORRECT]**
C. Six consecutive months of amenorrhea with elevated estradiol
D. Absence of menstrual periods for 24 months regardless of age
Correct Answer: B
Rationale: Natural menopause is a clinical, retrospective diagnosis established after 12 consecutive months of amenorrhea
without other pathological or physiological cause. This is the gold standard per NAMS position statements. Laboratory
evaluation with FSH and estradiol is not routinely required for women over age 45 because these hormone levels fluctuate
substantially during the menopausal transition and are not reliable for diagnosis. Neither six nor 24 months is the accepted
criterion.
Q5: A researcher is studying hormonal changes during the menopausal transition. Which of the following
best describes the pattern of inhibin B and anti-Mullerian hormone (AMH) during this period?
A. Both inhibin B and AMH increase progressively through the transition
B. Both inhibin B and AMH decrease, allowing growth of the remaining follicle pool **[CORRECT]**
C. Inhibin B decreases while AMH remains stable until late postmenopause
D. AMH increases while inhibin B decreases in the early transition
Correct Answer: B
Rationale: During the menopausal transition, both inhibin B and AMH decrease significantly. This decrease in inhibin B
removes its negative feedback on FSH, contributing to rising FSH levels. The decline in AMH reflects the diminishing
ovarian follicle pool. Per NAMS-endorsed understanding, the reduction in these markers is among the earliest detectable
hormonal changes of reproductive aging.
Q6: A 49-year-old perimenopausal woman presents with a sudden episode of breast tenderness and a brief
increase in menstrual flow after 4 months of light periods. Her clinician explains that this may represent a
Luteal Out-of-Phase (LOOP) event. What is the primary mechanism of a LOOP event?
A. Sudden drop in progesterone leading to endometrial destabilization
B. Elevated FSH recruits a second follicle causing transient estradiol elevation **[CORRECT]**
C. Abrupt cessation of all ovarian hormone production
D. Increased androgen production from the stromal compartment of the ovary
Correct Answer: B
Rationale: A Luteal Out-of-Phase (LOOP) event occurs when elevated FSH during the perimenopausal transition recruits a
second follicle, causing a transient estradiol elevation that can produce symptoms such as breast tenderness and heavier
menstrual bleeding. This is a well-described phenomenon in perimenopausal women and reflects the erratic hormonal
fluctuations characteristic of this stage. It does not involve progesterone drops, complete cessation of hormones, or androgen
excess.
Q7: What is the average age of natural menopause in the United States?
A. 45 years
B. 48 years
C. 51 years **[CORRECT]**
3
, D. 55 years
Correct Answer: C
Rationale: The average age of natural menopause in the United States is 51 years. This is a fundamental epidemiologic fact
established by large population studies and endorsed by NAMS. Early menopause is defined as the last menstrual period
(LMP) before age 45, and late menopause is defined as LMP after age 54. Primary ovarian insufficiency (POI) refers to
menopause before age 40.
Q8: A 42-year-old woman with regular menses and no symptoms asks about her reproductive stage.
According to STRAW+10, which stage is she most likely in?
A. Stage -3b (Early Reproductive)
B. Stage -3 (Late Reproductive) **[CORRECT]**
C. Stage -2 (Early Transition)
D. Stage -1 (Late Transition)
Correct Answer: B
Rationale: A woman in her early 40s with regular menstrual cycles and no menopausal symptoms is most likely in Stage -3
(Late Reproductive stage) of the STRAW+10 system. This stage is characterized by regular cycles but with the beginning of
subtle hormonal changes. Stage -3b (Early Reproductive) typically describes younger women. Stages -2 and -1 involve cycle
irregularity that this patient does not report.
Q9: A clinician is evaluating a 35-year-old woman with secondary amenorrhea for 5 months. Initial
laboratory evaluation for missed cycles should include which of the following?
A. FSH, LH, estradiol, and inhibin A only
B. Prolactin, FSH, estradiol, TSH, and hCG **[CORRECT]**
C. Testosterone, DHEA-S, and 17-hydroxyprogesterone only
D. Estradiol, progesterone, and cortisol only
Correct Answer: B
Rationale: The initial laboratory evaluation for missed menstrual cycles in a woman of reproductive age should include
prolactin (to exclude hyperprolactinemia), FSH (to assess ovarian function), estradiol (to evaluate estrogen status), TSH (to
exclude thyroid dysfunction), and hCG (to rule out pregnancy). This comprehensive panel addresses the most common causes
of secondary amenorrhea. Testing only a limited hormonal panel would miss important diagnostic information.
Q10: During the early postmenopausal period (Stage +1), which of the following hormonal and clinical
patterns predominates?
A. FSH stabilizes at low levels and somatic aging predominates
B. FSH rises, estradiol decreases, and vasomotor symptoms predominate **[CORRECT]**
C. Estrogen levels remain near premenopausal range for 3-5 years
D. Progesterone production continues at 50% of premenopausal levels
Correct Answer: B
Rationale: In Stage +1a, +1b, and +1c (Early Postmenopause, the first 2 years after the final menstrual period), FSH levels
rise significantly while estradiol levels decrease. Vasomotor symptoms (VMS) are the predominant clinical feature during
this stage. Somatic aging and increased genitourinary symptoms become more characteristic of Stage +2 (Late
Postmenopause), which occurs 5-8 years after the FMP.
4
2026/2027
Complete Questions and Solutions
Aligned with 2026-2027 The Menopause Society (formerly NAMS)
Certified Menopause Practitioner (NCMP) Examination Blueprint
Total Questions Question Format Cognitive Levels
25% Recall, 55% Application, 20%
100 MCQ (A-D), Single Best Answer
Analysis
Section 1: Menopause Physiology - Normal and Abnormal (Q1-Q20)
Section 2: Health Disorders of Peri- and Postmenopausal Women (Q21-Q35)
Section 3: Clinical Evaluation and Diagnostic Approach (Q36-Q50)
Section 4: Therapeutic Options - Hormone Therapy (Q51-Q65)
Section 5: Therapeutic Options - Non-Hormonal and Integrative Therapies (Q66-Q75)
Section 6: Bone Health and Osteoporosis Management (Q76-Q85)
Section 7: GSM and Sexual Health (Q86-Q92)
Section 8: Cardiovascular Health, Cancer Screening, and Long-Term Preventive Care (Q93-Q100)
1
,Section 1: Menopause Physiology - Normal and Abnormal
Q1: A 52-year-old woman presents to the clinic reporting irregular menstrual cycles over the past 8
months. Her cycles previously occurred every 28 days but now vary from 21 to 45 days. According to the
STRAW+10 staging system, which stage of reproductive aging best describes this patient?
A. Stage -2 (Early Transition) **[CORRECT]**
B. Stage -1 (Late Transition)
C. Stage +1a (Early Postmenopause)
D. Stage -3 (Late Reproductive)
Correct Answer: A
Rationale: The STRAW+10 staging system defines Stage -2 (Early Transition) by a persistent difference of 7 or more days in
the length of consecutive cycles. This patient's cycle variability (21-45 days, a difference exceeding 24 days) meets this
criterion. Stage -1 requires 60 or more consecutive days of amenorrhea, which is not reported here. Stages +1a and -3 do not
match the clinical presentation of cycle irregularity.
Q2: A 47-year-old woman reports that she has not had a menstrual period for the past 10 weeks. Prior to
this, her cycles had become increasingly irregular over the preceding year. Based on STRAW+10 criteria,
what is the minimum duration of amenorrhea required to classify her as being in the Late Menopausal
Transition (Stage -1)?
A. 30 consecutive days
B. 45 consecutive days
C. 60 consecutive days **[CORRECT]**
D. 90 consecutive days
Correct Answer: C
Rationale: The STRAW+10 staging system defines Stage -1 (Late Menopausal Transition) by the occurrence of 60 or more
consecutive days of amenorrhea. This patient meets the criterion with 70 days (10 weeks) of amenorrhea. Thirty days
represents a single missed cycle insufficient for staging. Forty-five days does not meet the STRAW+10 threshold. Ninety days
is excessive and not the defined criterion.
Q3: A clinician is educating a 38-year-old woman who was recently diagnosed with Primary Ovarian
Insufficiency (POI). Which of the following laboratory findings is most consistent with this diagnosis?
A. FSH level of 15 IU/L on a single measurement
B. FSH level of 30 IU/L on two measurements 4 weeks apart **[CORRECT]**
C. Elevated prolactin with normal FSH
D. Low estradiol with normal FSH and LH
Correct Answer: B
Rationale: POI is diagnosed in women under age 40 with amenorrhea for 3-4 months and elevated FSH of 25 IU/L or greater
on two checks performed 4-6 weeks apart. An FSH of 30 IU/L confirmed on two separate measurements meets this diagnostic
criterion. A single FSH measurement of 15 IU/L is insufficient and below the threshold. Elevated prolactin suggests a
different etiology. Low estradiol with normal gonadotropins points toward hypothalamic amenorrhea rather than POI.
Q4: A 55-year-old woman asks her healthcare provider when she can be formally diagnosed as
postmenopausal. According to NAMS guidelines, which of the following is the correct diagnostic criterion
2
,for natural menopause?
A. FSH level greater than 40 IU/L on two occasions
B. Twelve consecutive months of amenorrhea without other pathological or physiological cause
**[CORRECT]**
C. Six consecutive months of amenorrhea with elevated estradiol
D. Absence of menstrual periods for 24 months regardless of age
Correct Answer: B
Rationale: Natural menopause is a clinical, retrospective diagnosis established after 12 consecutive months of amenorrhea
without other pathological or physiological cause. This is the gold standard per NAMS position statements. Laboratory
evaluation with FSH and estradiol is not routinely required for women over age 45 because these hormone levels fluctuate
substantially during the menopausal transition and are not reliable for diagnosis. Neither six nor 24 months is the accepted
criterion.
Q5: A researcher is studying hormonal changes during the menopausal transition. Which of the following
best describes the pattern of inhibin B and anti-Mullerian hormone (AMH) during this period?
A. Both inhibin B and AMH increase progressively through the transition
B. Both inhibin B and AMH decrease, allowing growth of the remaining follicle pool **[CORRECT]**
C. Inhibin B decreases while AMH remains stable until late postmenopause
D. AMH increases while inhibin B decreases in the early transition
Correct Answer: B
Rationale: During the menopausal transition, both inhibin B and AMH decrease significantly. This decrease in inhibin B
removes its negative feedback on FSH, contributing to rising FSH levels. The decline in AMH reflects the diminishing
ovarian follicle pool. Per NAMS-endorsed understanding, the reduction in these markers is among the earliest detectable
hormonal changes of reproductive aging.
Q6: A 49-year-old perimenopausal woman presents with a sudden episode of breast tenderness and a brief
increase in menstrual flow after 4 months of light periods. Her clinician explains that this may represent a
Luteal Out-of-Phase (LOOP) event. What is the primary mechanism of a LOOP event?
A. Sudden drop in progesterone leading to endometrial destabilization
B. Elevated FSH recruits a second follicle causing transient estradiol elevation **[CORRECT]**
C. Abrupt cessation of all ovarian hormone production
D. Increased androgen production from the stromal compartment of the ovary
Correct Answer: B
Rationale: A Luteal Out-of-Phase (LOOP) event occurs when elevated FSH during the perimenopausal transition recruits a
second follicle, causing a transient estradiol elevation that can produce symptoms such as breast tenderness and heavier
menstrual bleeding. This is a well-described phenomenon in perimenopausal women and reflects the erratic hormonal
fluctuations characteristic of this stage. It does not involve progesterone drops, complete cessation of hormones, or androgen
excess.
Q7: What is the average age of natural menopause in the United States?
A. 45 years
B. 48 years
C. 51 years **[CORRECT]**
3
, D. 55 years
Correct Answer: C
Rationale: The average age of natural menopause in the United States is 51 years. This is a fundamental epidemiologic fact
established by large population studies and endorsed by NAMS. Early menopause is defined as the last menstrual period
(LMP) before age 45, and late menopause is defined as LMP after age 54. Primary ovarian insufficiency (POI) refers to
menopause before age 40.
Q8: A 42-year-old woman with regular menses and no symptoms asks about her reproductive stage.
According to STRAW+10, which stage is she most likely in?
A. Stage -3b (Early Reproductive)
B. Stage -3 (Late Reproductive) **[CORRECT]**
C. Stage -2 (Early Transition)
D. Stage -1 (Late Transition)
Correct Answer: B
Rationale: A woman in her early 40s with regular menstrual cycles and no menopausal symptoms is most likely in Stage -3
(Late Reproductive stage) of the STRAW+10 system. This stage is characterized by regular cycles but with the beginning of
subtle hormonal changes. Stage -3b (Early Reproductive) typically describes younger women. Stages -2 and -1 involve cycle
irregularity that this patient does not report.
Q9: A clinician is evaluating a 35-year-old woman with secondary amenorrhea for 5 months. Initial
laboratory evaluation for missed cycles should include which of the following?
A. FSH, LH, estradiol, and inhibin A only
B. Prolactin, FSH, estradiol, TSH, and hCG **[CORRECT]**
C. Testosterone, DHEA-S, and 17-hydroxyprogesterone only
D. Estradiol, progesterone, and cortisol only
Correct Answer: B
Rationale: The initial laboratory evaluation for missed menstrual cycles in a woman of reproductive age should include
prolactin (to exclude hyperprolactinemia), FSH (to assess ovarian function), estradiol (to evaluate estrogen status), TSH (to
exclude thyroid dysfunction), and hCG (to rule out pregnancy). This comprehensive panel addresses the most common causes
of secondary amenorrhea. Testing only a limited hormonal panel would miss important diagnostic information.
Q10: During the early postmenopausal period (Stage +1), which of the following hormonal and clinical
patterns predominates?
A. FSH stabilizes at low levels and somatic aging predominates
B. FSH rises, estradiol decreases, and vasomotor symptoms predominate **[CORRECT]**
C. Estrogen levels remain near premenopausal range for 3-5 years
D. Progesterone production continues at 50% of premenopausal levels
Correct Answer: B
Rationale: In Stage +1a, +1b, and +1c (Early Postmenopause, the first 2 years after the final menstrual period), FSH levels
rise significantly while estradiol levels decrease. Vasomotor symptoms (VMS) are the predominant clinical feature during
this stage. Somatic aging and increased genitourinary symptoms become more characteristic of Stage +2 (Late
Postmenopause), which occurs 5-8 years after the FMP.
4
